Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation | PNAS
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML
Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis | Disease Models & Mechanisms
Recombinant human NFkB Inducing Kinase NIK protein (ab105210) | Abcam
Identification of p53 as a negative regulator of NIK protein and the... | Download Scientific Diagram
RCSB PDB - 4DN5: Crystal Structure of NF-kB-inducing Kinase (NIK)
NIK protein degradation induced by GA is largely mediated by autophagy.... | Download Scientific Diagram
NIK–IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation | Journal of Cell Science
MAP4K4 recombinant protein | NIK Recombinant Protein-BAA33714.1
NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
Hsp90 function is required for the increase of NIK protein mediated by... | Download Scientific Diagram
Frontiers | Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I1/2 NIK Inhibitors | Pharmacology
Recombinant human NFkB Inducing Kinase NIK protein (ab105210) | Abcam
NIK as a Druggable Mediator of Tissue Injury - ScienceDirect
Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy | Experimental oncology
Recombinant human NFkB Inducing Kinase NIK protein (ab105210) | Abcam
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
![RCSB PDB - 4IDV: Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V)](https://cdn.rcsb.org/images/structures/id/4idv/4idv_assembly-1.jpeg "RCSB PDB - 4IDV: Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V)")
RCSB PDB - 4IDV: Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V)
Small-molecule drug targeting NIK protein specifically reduces HL cell... | Download Scientific Diagram
NIK protein level and activity are controlled by a negative feedback... | Download Scientific Diagram
NIK Antibody
Schematic representation of NIK protein domain structures. The NRD... | Download Scientific Diagram
Expression levels of NIK protein are correlated with those of its mRNA... | Download Scientific Diagram
Bacterial internalization is required to trigger NIK-dependent NF-κB activation in response to the bacterial type three secretion system
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
